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Research
AbstrACt
Objectives We explored children’s views on research 
without prior consent (RWPC) and sought to identify ways 
of involving children in research discussions.
Design Qualitative interview study.
setting Participants were recruited through a UK 
children’s hospital and online advertising.
Participants 16 children aged 7–15 years with a 
diagnosis of asthma (n=14) or anaphylaxis (n=2) with 
recent (<12 months) experience of emergency care.
results Children were keen to be included in medical 
research and viewed RWPC as acceptable in emergency 
situations if trial interventions were judged safe. Children 
trusted that doctors would know about their trial 
participation and act in their best interests. All felt that 
children should be informed about the research following 
their recovery and involved in discussions with a clinician 
or their parent(s) about the use of data already collected 
as well as continued participation in the trial (if applicable). 
Participants suggested methods to inform children about 
their trial participation including an animation.
Conclusions Children supported, and were keen to be 
involved in, clinical trials in emergency situations. We 
present guidance and an animation that practitioners and 
parents might use to involve children in trial discussions 
following their recovery. 
IntrODuCtIOn
Informed consent for participation in 
research is a key principle of good clinical 
practice and protects an individual’s right to 
autonomy.1 2 Children under the age of 16 
years are not legally permitted to give consent 
for their participation in clinical trials of drug 
treatments.3 Nevertheless, the United Nations 
Convention on the Rights of the Child,4 inter-
national legislation5 and research guidelines6 
recommend that children should be involved 
in decision making processes in a way that is 
age appropriate to the child and the context 
of their family. The term assent is widely 
used and refers to when a child’s wishes are 
taken into consideration in research deci-
sion making. It is recommended that assent 
is sought from children before they take 
part in research, where informed consent is 
not possible, although the role of assent has 
been criticised for being unclear in research 
discussions with children.7 8
Neither informed consent nor assent 
are appropriate or feasible in acute paedi-
atric emergency situations,9 as children are 
incapacitated and the time taken to discuss 
research with parents could delay lifesaving 
treatments.10 11 To facilitate crucial clinical 
research and to advance evidence-based 
emergency medicine,12 changes to interna-
tional legislation have allowed doctors to 
enter patients into clinical research without 
prior consent (RWPC).3 13–16 In the UK, 
RWPC, also known as deferred consent, 
involves approaching parents or legal repre-
sentatives after the investigational treatment 
has been given and seeking permission for 
the use of data already collected as well as any 
continued participation in the trial.17
Guidance18 and legislation15 state that 
where possible, children should be involved 
in RWPC discussions once they have recov-
ered. However, practitioners report that 
strengths and limitations of this study
 ► This is the first study to explore the views and ac-
ceptability of research without prior consent (RWPC) 
among children with experience of receiving emer-
gency treatment for life-threatening conditions.
 ► We provide guidance and an animation to assist trial 
practitioners in involving children in RWPC discus-
sions in collaboration with parents.
 ► Participants did not have personal experience of 
RWPC, so findings were limited to children’s views 
on hypothetical scenarios.
 ► Participants lived in areas with varied levels of social 
deprivation. Despite attempts to further maximise 
sample diversity by use social media, the majority 
of children were recruited from one UK children’s 
hospital.
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RWPC discussions with parents take place at the bedside, 
shortly after the emergency situation has passed and that 
children are rarely involved at this point because they 
are too sick.19 It is therefore likely that most children 
randomised into UK trials conducted in time critical situ-
ations have no knowledge or involvement in the decision 
about their participation in emergency research.
Despite growing literature on the views of parents and 
practitioners regarding paediatric trials conducted in 
life-threatening situations,18 20 21 the opinions of children 
have not been investigated. This is an important omis-
sion as it is they who are most directly affected in this 
process. We aimed to explore children’s perspectives on 
paediatric emergency research, including their views on 
the acceptability of RWPC and ways of involving them in 
RWPC discussions when they have recovered.
MethODs
study design and setting
We chose a qualitative interview design to help us explore 
children’s views in a flexible, child friendly way and to 
provide insight into children’s perspectives on RWPC.22 23 
We recruited children for interviews through a children’s 
hospital in the North West of England, supplemented by 
online-advertising to promote sample diversity.
Patient and public involvement
Six members of the National Institute for Health Research 
(NIHR) Young Person’s Advisory Group (YPAG) joined 
our ‘Voices Advisory Group’ to inform all aspects of the 
study. This included their collaboration in the devel-
opment of recruitment materials, a topic guide, which 
included age-appropriate explanations of key topics (eg, 
RWPC; see online supplementary file 1) and vignette 
(see online supplementary file 2). KW and LR discussed 
initial findings with the Voices Advisory Group to assist 
analysis and interpretation. Members of the Voices Advi-
sory Group also presented the findings with KW to a wide 
audience (at conferences and University events).
selection of participants
Children were eligible if they were aged 7–15 years; had 
written parental/legal representative consent to partic-
ipate; had received emergency treatment in hospital in 
the previous 12 months; had capacity to assent and an 
acceptable standard of English.
Two clinical practitioners identified and approached 
parents and children who met the inclusion criteria, 
explained the aims of the study and provided age appro-
priate information sheets. Parents of the children who 
wished to participate completed a contact form, which 
was posted to LR. For online recruitment, FS contacted 
relevant support groups and asked them to place a study 
advertisement (online supplementary file 3) on their 
Facebook page, Twitter account or website. The advert 
included details of how children or parents could contact 
the study team to register interest in participation.
Interview design and conduct
LR, a health psychologist arranged interviews either in 
the family’s home, hospital or by telephone depending 
on participant preference. Before interviews, LR 
explained the study, referring to the information sheets 
and consent/assent forms provided. Consent and assent 
forms were completed by parents and children before the 
interview began.
We began interviews by showing children the Nuff-
ield Council’s animation6 on a laptop or iPad to help set 
the scene and explain clinical research participation in 
a child-friendly way. No child had previous experience 
of RWPC, although they all had experienced at least 
one episode of receiving emergency care. We presented 
RWPC neutrally so that children could give their views 
freely. We also reassured children that there were no right 
or wrong answers.
LR conducted all interviews. Recruitment and interviews 
were discontinued when data saturation was reached, that 
is, the point where no new themes were discovered in the 
analysis.24 Interviews were audio-recorded, transcribed 
verbatim and then anonymised. Participants were given a 
£10 shopping voucher and a certificate of participation as 
appreciation for their time.
Data analysis
Our approach to data analysis was interpretive and itera-
tive, referring back and forth between developing analysis 
and gathering new data for evidence of children’s views 
on research in emergency situations, the acceptability 
of RWPC and ways of involving children in discussions 
about research in this context.25 26 A key consideration 
during analysis was that of catalytic validity, whereby 
findings should be relevant to future research and prac-
tice.27 NVivo software assisted data organisation. Several 
members of the research team (KW, LR, FS, BY) contrib-
uted to the analysis to ensure analytical rigor.26 28 We 
present selected interview quotations (with pseudonyms) 
that illustrate research themes across a range of partici-
pants. Where quotes have been shortened for brevity or to 
remove identifiable information, omitted text is marked 
with ‘…’ and explanatory text is in brackets.
results
Participants
Sixteen children (aged 7–15 (mean 10.2) years) were 
interviewed. At the children’s request, parents were 
present for most of the interviews (n=12/16, 75%). Most 
participants had chronic asthma (n=14/16, 87%) and 
were recruited by a paediatric doctor (PM) in an outpa-
tient clinic or hospital ward (n=2/16, 13%). Two partic-
ipants suffered with anaphylaxis and were recruited via 
Facebook. Interviews averaged 34 min in length, ranging 
from 21 to 57 min (table 1). Participants’ postcodes indi-
cated that 9/16 (56%) participants lived in areas of high 
deprivation (Indices of Multi-Deprivation (IMD) decile 
1–3), 5/16 (31%) lived in areas of moderate deprivation 
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(IMD decile 4–6), while 2/16 (13%) children lived in the 
least deprived (IMD decile 7–10) areas of the UK.29
support for rWPC, but only if a trial treatment was judged 
safe
All children voiced support for RWPC in emergency situ-
ations where a child’s life was in danger, such as during 
an asthma attack or seizure. They explained that while 
parents and children should usually be asked for ‘permis-
sion’ before the research takes place, RWPC was accept-
able in emergency research as it is important that doctors 
were able to give trial medicines without any delay in this 
situation.
Chloe, aged 12: most of the time (in research) you should 
ask the permission from the parents and the children… I 
think they can do that (research) without asking for permis-
sion because if it’s an emergency and you have to give the 
medicine.
The researcher (and the vignette of Daniel, see S3), 
informed children that only medicines that were believed 
to be safe would be used in paediatric trials. Children 
viewed this information as important, indeed, many 
stated that RWPC was only acceptable if doctors thought 
the treatment being tested was safe.
Josh, aged 11: If, say, like you’re giving them a drug that 
hasn’t been proven to have high probability of being safe, I 
don’t think it would be good to give it them, but if it was 
probably going to be safe for them, I think they’d be fine.
One child supported RWPC in the hope that the 
treatment being tested would help children to recover 
more quickly and to inform future paediatric medicine. 
However, he warned that parents may have a different 
perspective and may be angry to find out that their child 
had been entered into a trial without informed consent if 
it turned out that the treatment was not effective.
Researcher: So what do you think about doing research 
without asking parents or children when they’re very sick?
James aged 11: I think the parents would be a bit ticked 
off like because they just want to get their child better, like I 
know my mum definitely would be…I would like it because 
if that drug did work on the off-chance then I would want 
to tell people (other children with chronic health conditions).
Misconceptions and misunderstandings
Many children appeared to understand that trials ‘try to see 
if’ the medicine being investigated makes children ‘better 
or not’ (Lola aged 7). However, a few children appeared to 
hold a misconception that research participation would 
have similar benefits to clinical care. For some children, 
this misconception seemed to be linked to the involve-
ment of clinicians in the trial. Children stated they would 
not be upset about being entered into a RWPC trial as long 
as ‘the doctors know’ (Emily aged 15) about their partic-
ipation. As the quotes below suggest, children trusted 
clinicians to have their best interests at heart and wanted 
assurance that doctors and nurses would know about, and 
have approved, their involvement in a trial.
Researcher: So what if they gave you a new type of nebu-
liser and not told you? Do you think if it's that type of thing 
you should have been asked (about beforehand), or do you 
still think it's (RWPC is) okay?
Emily aged 15: The doctors know (about being given a 
trial intervention)?
Researcher: The doctors yes.
Emily aged 15: Oh yes, definitely.
Researcher: Would you be upset that they have tried some-
thing on you and not asked you first?
Ryan aged 8: No.
Researcher: Why is that?
Ryan aged 8: Because the doctors and the nurse, they know.
Others believed that within a trial, children would 
receive the ‘right’ treatment, while another implied that 
RWPC would only be acceptable if the intervention was 
effective:
Daisy aged 7: He’ll (Daniel) get the right medicine to make 
him feel better.
Tilly aged 14: I don't see the problem if it's going to stop it 
(anaphylaxis).
Why children want to be informed and involved in rWPC 
discussions
Children felt strongly they should be involved in RWPC 
discussions when they were feeling better. Several asked 
rhetorically, ‘Why shouldn’t we be told?’ when asked 
about their participation in research. Irrespective of their 
Table 1 Participant and interview details
Pseudonym Gender Age Health condition
Parent 
present
Chloe Female 12 Asthma Yes
Charlie Male 7 Asthma Yes
James Male 11 Asthma Yes
Emily Female 15 Asthma No
Niamh Female 15 Asthma Yes
Kaitlin Female 8 Asthma Yes
Joseph Male 7 Asthma Yes
Josh Male 11 Asthma Yes
Mia Female 9 Asthma Yes
Daisy Female 7 Asthma Yes
Kevin Male 8 Asthma Yes
Patrick Male 9 Asthma No
Lola Female 7 Asthma Yes
Ryan Male 8 Asthma Yes
Tom Male 15 Anaphylaxis No
Tilly Male 15 Anaphylaxis No
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age, children reasoned they should be informed about 
the treatment received in a trial because ‘it’s going to impact 
on their body’ (Tilly, aged 14) not their parents’ bodies. 
Indeed. Tilly added that not being informed about their 
participation in a trial would ‘feel like I’d been sort of left out, 
like my opinions and views sort of, I don’t get to express them’ 
suggesting that not being included in RWPC discussion 
would deny children their voice and the opportunity to 
have a say in their healthcare treatment.
A few children described wanting to be informed about 
their involvement in research and the trial results to ‘know 
what the trial had proved’ (Chloe aged 12) for their own 
chronic health condition. They expressed a wish to help 
inform future knowledge about treatments for other chil-
dren by finding ‘out about new medicines on the computer that 
are better than other ones and then they could give us it and then 
it might make us better’. (Joseph aged 7).
Finally, two young boys (<12 years) wanted to know about 
their participation because they viewed medical research 
as exciting. For them, children should be informed about 
their participation in research because ‘it could be fun to 
take part in stuff’ (Joseph, aged 7) and ‘it’s quite cool to be 
part of like a scientific medical thing’ (Josh, aged 11).
Who should explain rWPC to children?
Most children commented that the best person to explain 
that they had participated in a study while they were ill 
would be a doctor or nurse as they would be the most 
knowledgeable.
Tilly, aged 14: if it's a nurse who knows all about it and 
then also has studied kids, they can then help with that as 
well, help them do it, understand what's happened and go 
through it. But I don't think I'd listen if my mum told me. I 
would want it more, the medical advice really.
Kaitlin, aged 8: By the doctor … because he can explain 
it more.
Some envisaged they would have questions about the 
research which they would like a doctor or nurse to 
answer, such as: ‘How could it affect me? What would be like 
the aftermath of it?’ (James aged 11), ‘What could the risks 
be?’ (Joseph aged 7) as the doctor or nurse would be best 
placed to answer.
Although some children said they ‘wouldn’t mind who 
told’ (Chloe aged 12) them about their participation in a 
trial, a few younger children stated that they would prefer 
to be informed by their mothers because it may ‘feel a bit 
awkward’ talking to the doctors and its ‘easier with my mum’ 
(Mia aged 9).
Children’s role in decisions about the use of their information
Children varied in their views about the role of children in 
RWPC decisions when they were feeling better. Younger 
children were typically happy for their parents (mainly 
mothers) to make the final decision about the use of their 
information in a trial.
Kevin aged 8: Up to my mum.
 Joseph, aged 7: I would listen to my mum and the doctors 
because older people can sometimes be cleverer than younger 
people than them, because they’ve had more years to learn 
about stuff.
Participants of all ages echoed this by commenting that 
children younger than themselves, ‘don’t really understand 
[…] what the research is about’ (Chloe aged 12) and ‘might 
be a bit too young’ (Joseph aged 7) to make such decisions 
and that for such children it should be a parent’s role to 
make a decision about the use of their information for 
research purposes.
Similarly, some children stated that they would accept 
their parents’ decision, even if it was at odds with their own 
views, while others wanted to share in decision-making 
with their mothers.
Emily aged 15: My little brother, he's 11 and I think he's 
sensible so he'd probably choose the right thing. But if you’re 
a bit younger I think it should be up to your mum.
James, aged 11: If mum said no and I said yes, I would 
just listen to mum.
Researcher: What about if you wanted to be in it but mum 
said no, then who should (the doctor) listen to?
Chloe, aged 8: Both of us.
In contrast, a few teenage participants felt that ‘they 
should be able to actually make a medical choice for them-
selves because it's impacting them in the end’ (Tilly aged 14). 
Therefore, their decision about the use of their data and 
involvement in any follow-up, should override, or at least 
have greater value, than their parents’ decisions.
Researcher: What if your mum says yes, that's fine and 
you say no? Then who should be in charge?
Emily aged 15: Me.
Child friendly resources to help communicate rWPC: 
introducing the ‘You took part in research animation’
Finally, we sought participants’ suggestions on the most 
appropriate resources to help to engage with children in 
RWPC discussions when they were feeling better. Partici-
pants emphasised the need for a face to face discussion 
so doctors or nurses could ‘explain it to you, or give you a 
leaflet, then…you can ask questions in person’ (Chloe aged 
12). While a few suggested that leaflets, websites and 
picture books would be useful in explaining RWPC, most 
favoured an online animation that could be used either 
in hospital as part of a face to face discussion, or ‘at some 
point when I was at home’ (Tom aged 13) to ‘make sure they 
understand everything properly’ (Josh aged 11) to explain 
RWPC.
Patrick aged 9: because some doctors don’t know how far to 
explain stuff when they are particularly young kids. So even 
the doctors to have on their phone or their iPad and go this 
is what we’ve done, and then they watch it and then they 
explain a bit more then.
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The findings of this study encouraged the study team 
to develop an animation with the help of the Voices 
Advisory Group and three of interviewees in the current 
study who wished to help with this. The ‘You took part 
in research’ animation available to view on YouTube 
(https://www. youtube. com/ watch? v=_ Fs1yUxeBFQ), 
focuses on explaining why consent could not be sought 
before a child took part in research.
DIsCussIOn
We believe this is the first study to explore the views and 
acceptability of RWPC among children with experience 
of receiving emergency treatment in hospital. The chil-
dren we interviewed supported RWPC in the hope that 
such research would contribute to developments in chil-
dren’s emergency medicine for the benefit of themselves 
and other children. However, RWPC was only acceptable 
to children where trial interventions were believed by the 
clinicians caring for them to be safe. This finding also 
echoes previous literature on therapeutic misconceptions 
about trial participation among adults,30 as some children 
held the misconception that research participation would 
have similar benefits to clinical care. Others appeared to 
trust that doctors would know about their trial participa-
tion and act in their best interests. Others believed that 
within a trial, children would receive the ‘right’, treat-
ment. Such findings suggest that trial information mate-
rials and practitioner RWPC discussions should clearly 
explain that doctors don’t know which intervention is 
the best, which is why a trial is needed. This information 
should be supplemented with details of other treatments 
given (if applicable) and any additional monitoring that 
occurred.
This study has strengths and limitations. This is the 
first study to explore the views and acceptability of RWPC 
among children with experience of receiving emergency 
treatment in hospital. We strengthened our qualitative 
sampling by conducting interviews until no new relevant 
knowledge was obtained from new participants (data 
saturation). All participants had a chronic health condi-
tion and experienced multiple hospital admissions for 
emergency lifesaving treatments. However, our findings 
do not reflect the views of acutely ill children admitted 
to hospital for the first time. Participants did not have 
personal experience of emergency medicine research so 
findings were limited to children’s views on hypothetical 
scenarios about RWPC. Finally, the study findings are 
mainly limited to the views of children recruited from an 
asthma clinic in one UK children’s hospital. Neverthe-
less, there was variation in the sample, as children lived 
in areas with differing levels of social deprivation. Despite 
the successful use of websites and social media advertising 
to recruit parents to similar qualitative studies,21 31 only 
two children responded to social media advertisement. 
The low response to this indicates social media such as 
Facebook and Twitter may not be an effective route for 
recruiting children to research. Placing adverts on social 
media more commonly used by children (eg, Snapchat)32 
may have been more successful.
Children’s support of RWPC in emergency situation 
reflects the findings of previous studies on this topic 
involving trial practitioners and parents.18 19 21 31 33 Where 
studies18 19 31 have shown that parents can have initial 
negative responses to RWPC, children did not appear 
to be shocked or surprised at this alternative to giving 
informed consent before the research intervention. This 
may reflect their lack of familiarity with standard research 
consent processes, or indeed, their lack of previous 
involvement in decisions about their healthcare. Our 
findings suggest that children trust doctors and parents 
to make appropriate decisions about their participation 
in research when they are unable to do so themselves. 
However, children were clear that when they were feeling 
better, adults (particularly mothers and doctors) should 
inform them of their trial participation and discuss the 
use of their data.
Children in our study acknowledged the important 
role that children, parents and doctors played in research 
decision making. This reflects guidelines recommending 
that decisions about research should involve discus-
sion and information exchange between children, their 
parents and doctors.6 12 34–36 Some described the pros-
pect of research participation as exciting and fun, while 
others seemed to want the satisfaction of knowing if they 
had contributed to research that might improve future 
treatments for both themselves and others. Children 
wanted to be involved in decisions regarding their own 
healthcare.37 38 Younger children were happy for their 
parents to take the lead or a shared role in research deci-
sion-making. A few teenagers felt their views should carry 
greater weight than their parents suggesting that practi-
tioners should be aware of the possibility that teenagers 
may wish to take a lead in such decisions. As previous 
literature19 21 31 and Voices study findings all show support 
for RWPC, we do not anticipate divergence in child and 
parent views on consent in this situation, mainly because 
the intervention has already been given and children 
have commonly recovered when research discussions take 
place. The challenge is ensuring children are given the 
opportunity to be (retrospectively) informed about their 
research participation and actively involved in research 
discussions and decision making with their parents.
We acknowledge there may be practical barriers to 
involving children in RWPC discussions, as they may not 
be well enough or have the capacity to be involved before 
discharge from hospital. Nevertheless, our findings19 
indicate that when they have recovered, children are not 
given the opportunity to know they have participated in 
research or a say in whether their data continue to be 
used in research. Based on the accounts of the children 
we interviewed, this is unlikely to be acceptable to chil-
dren who participate in trials to evaluate interventions 
used in emergency care. As one child we interviewed 
eloquently stated, ‘it's not impacting their life, it's impacting 
your own’ (Tilly, aged 15).
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Box 1 (guidance to inform and involve children in 
RWPC discussions) provides an update to CONNECT 
study RWPC guidance,39 which aims to assist trial prac-
titioners in involving children in RWPC discussions in 
collaboration with parents. To respect the wishes of 
children we encourage trial staff to involve them in trial 
discussions in hospital if they are well enough. The ‘You 
took part in research’ animation can be used to support 
these discussions. If this is not possible before children 
are discharged from hospital. Age-appropriate informa-
tion can be provided to facilitate family discussions about 
trial participation at home, including contact details if 
children wish to discuss their participation with the trial 
team. While our focus in this paper has been children 
(under 16 years), we believe our findings also relate to 
trial discussions with young people (16–18 years).
Further research is needed to explore the experiences 
of children with first-hand experience of RWPC and asso-
ciated discussions.
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